Recombinant Hepatitis E Vaccine

[Dosage form] 
Liquid for injection

[Indication] 
It is indicated for prevention against  hepatitis E for the persons aged 16 years and above. 

[Specification] 

0.5ml/dose/syringe, each dose contains 30μg of purified recombinant hepatitis E virus antigen.
[Route of Administration]
Intramuscular injection
[Shelf Life] 

36 months